The Na + ‐activated K + channel Slack (also known as KCNT1, Slo2.2, or KCa4.1) is widely expressed throughout the central nervous system, where it contributes to the slow afterhyperpolarization and is involved in controlling bursting behavior and spike frequency adaptation. Gain‐of‐function mutations in Slack have recently been shown to cause malignant migrating partial seizures of infancy. K Na channels further have long been known to protect cells from hypoxic injury. Slack activators therefore should be therapeutically useful for reducing neuronal excitability in epilepsy and ataxia as well as for the prevention of hypoxia associated neuronal damage in stroke and cerebral palsy. Slack channel activity is increased by the antiparasitic compounds bithionol and niclosamide. However, while bithionol is a positive gating‐modulator that requires intracellular sodium to be elevated to exert an effect, niclosamide is a true opener that activates Slack currents in whole‐cell patch‐clamp experiments even with a KF containing intracellular solution in the nominal absence of both Na + and Ca 2+ . Both types of Slack channel activators can be detected by resonance wavelength grating optical biosensors (the SRU Biosystems BIND), a high‐throughput assay measuring changes in mass at the plasma membrane. We are currently using this assay to screen for both Slack channel activators and inhibitors. Supported by R21 NS073943